7 7

Cited 0 times in

2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

Authors
 Philip Kam-Tao Li  ;  Sunita Bavanandan  ;  Rosmawati Mohamed  ;  Cheuk-Chun Szeto  ;  Vincent Wai-Sun Wong  ;  Kai-Ming Chow  ;  Yock-Young Dan  ;  Chiu-Ching Huang  ;  Ching-Lung Lai  ;  Tawesak Tanwandee  ;  Boon Wee Teo  ;  Grace Lai-Hung Wong  ;  Eng-Kiong Yeoh  ;  Kunitoshi Iseki  ;  Chi-Bon Leung  ;  Hyeong Cheon Park  ;  Talerngsak Kanjanabuch  ;  Wanhong Lu  ;  James Fung  ;  Jidong Jia  ;  Eiichiro Kanda  ;  Man-Ching Law  ;  Hong Liu  ;  Ching-Kong Loo  ;  Siu-Ka Mak  ;  Sing-Leung Lui  ;  Hon-Lok Tang  ;  Angela Yee-Moon Wang  ;  Ming-Lung Yu  ;  Michael Cheung  ;  Michel Jadoul 
Citation
 KIDNEY INTERNATIONAL REPORTS, Vol.5(8) : 1129-1138, 2020-05 
Journal Title
 KIDNEY INTERNATIONAL REPORTS 
Issue Date
2020-05
Keywords
chronic kidney disease ; dialysis ; direct-acting antiviral ; infection control ; kidney transplantation
Abstract
In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.
Files in This Item:
T202003388.pdf Download
DOI
10.1016/j.ekir.2020.05.001
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Park, Hyeong Cheon(박형천) ORCID logo https://orcid.org/0000-0002-1550-0812
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/179173
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links